IP Library Granted Patent US 8,728,723
Granted Patent B2
US 8,728,723 · App. 13/435,325 · Granted May 20, 2014

Method for simultaneously detecting an antigen of, and an antibody against, an infectious microorganism

Inventors: François Rieunier (Bois d'Arcy, FR); Muriel Feyssaguet (Saint Cloud, FR); Stéphanie Henriot (Suresnes, FR); Nadine Lambert (Chatou, FR)
Assignee: Bio-Rad Innovations
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,728,723
App. No.
13/435,325
Granted
May 20, 2014
Kind
B2
Abstract

The invention relates to a method for detecting, in vitro, an infection with a microorganism, such as the hepatitis C virus, in a biological sample, by simultaneously detecting an antigen of this microorganism and the antibodies against this same antigen, and also to the reagents and kits implementing this method.

Claims (14)

1. A kit which is of use for detecting an infection with human immunodeficiency virus (HIV) in a biological sample, comprising:

a) a capture or detection antigen which comprises an antigenic fragment of a gag protein of HIV, said fragment comprising at least one destroyed epitope, while at the same time conserving the ability to bind the antibodies directed against HIV possibly present in the biological sample; and

b) a capture or detection antibody directed against said epitope, which is intact, of said gag protein of HIV;

wherein the antigenic fragment comprises sequence FRGYVGRFYKTLRAEQAGQGVKNFMTETLLVQNANPDCKTILKALGPAATLEEMMTAC SEQ ID NO: 22.

2. The kit as claimed in claim 1 , in which the antibody is an antibody for capturing the HIV antigen present in the biological sample.

3. The kit as claimed in claim 1 , in which the antibody recognizes an epitope of sequence QASQEVKNWMTETLL (SEQ ID NO: 24).

4. The kit as claimed in claim 1 further comprising, besides the capture antigen, means of detecting the anti-HIV antibodies present in the biological sample, the detecting means forming complexes with the capture antigen.

5. The kit as claimed in claim 4 , wherein the detecting means is a labeled anti-immunoglobulin or anti-isotype antibody.

6. The kit as claimed in claim 1 , wherein the capture antibody and the capture antigen are present in a form immobilized on a solid phase.

7. The kit as claimed in claim 6 , further comprising:

c1) a labeled detection antibody directed against another of the epitopes, which are intact, of the HIV protein; and

c2) optionally a labeled detection antigen which is an antigenic fragment of the gag protein of HIV, the fragment comprising at least one other destroyed epitope, while at the same time conserving the ability to bind the anti-HIV antibodies possibly present in a biological sample.

8. The kit as claimed in claim 1 , also comprising at least one detergent of the nonionic type.

9. The kit as claimed in claim 8 , wherein the at least one detergent is NP40.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 8, 2019
From: BIO-RAD INNOVATIONS
To: BIO-RAD EUROPE GMBH
Reel/Frame 049122/0754 →
CHANGE OF NAME Recorded Mar 20, 2014
From: BIO-RAD PASTEUR
To: BIO-RAD INNOVATIONS
Reel/Frame 032481/0320 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 12, 2014
From: RIEUNIER, FRANCOIS; FEYSSAGUET, MURIEL; HENRIOT, STEPHANIE; LAMBERT, NADINE
To: BIO-RAD PASTEUR
Reel/Frame 032411/0749 →
Continuity (4)
Division 12076090 · Mar 13, 2008
Division 10431587 · May 8, 2003
Provisional Application 60379146 · May 10, 2002
Related Publication 20130157255A1 · Jun 20, 2013